Neurology
RSSArticles
-
Pharmacology Update: Romiplostim Injection (Nplate™)
A new agent has been approved by the fda for the treatment of thrombocytopenia associated with chronic immune thrombocytopenia purpura (ITP). -
It's Time to Have the Talk
Terminally ill cancer patients who had end-of life discussions with their physician had better quality of life during their last week and their caregivers had an easier bereavement. -
Full November 1, 2008 Issue in PDF
-
Pharmacology Watch
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions. -
Clinical Briefs in Primary Care Supplement
-
Clinical Briefs in Primary Care supplement
-
Botulinum Toxin Type A in Painful Focal Neuropathy
There is promising evidence that botulinum toxin type A provides analgesia in patients with painful focal neuropathy independent of its neuromuscular blocking action. -
IV Thrombolysis 3-4.5 Hours After Stroke: Time for a Change?
Intravenous thrombolysis is safe and effective for the treatment of ischemic stroke in the time window of 3-4.5 hours after the onset of symptoms. -
Full November 1, 2008 Issue in PDF
-
Pharmacology Watch
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.